Structure-dependent pseudoreceptor intracellular traffic of adamantyl globotriaosyl ceramide mimics

Journal of Biological Chemistry

Volumn 287, Issue 20, 2012, Pages 16073-16087

  Saito, Mitsumasa ^a,c   Mylvaganum, Murugespillai ^a   Tam, Patty ^b   Novak, Anton ^a   Binnington, Beth ^a   Lingwood, Clifford ^a,b  

^a HOSPITAL FOR SICK CHILDREN RESEARCH INSTITUTE   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c KYUSHU UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ADAMANTANES; AMPHIPATHIC; CELL SURFACES; CERAMIDES; CHOLERA TOXIN; CYTOSOLIC; ENDOPLASMIC RETICULUM; ENDOSOMES; JURKAT CELL; MEMBRANE CHOLESTEROL; PHOSPHOLIPID LIPOSOMES; PROTEIN SYNTHESIS; SHIGA TOXIN; VACUOLAR MEMBRANES; VERO CELLS;

AMIDES; CELL MEMBRANES; CHOLESTEROL; LIPOSOMES; PHOSPHOLIPIDS; UREA;

CYTOLOGY;

ADABISADAMANTYL GLOBOTRIAOSYLCERAMIDE; ADAMANTYL GLOBOTRIAOSYLCERAMIDE DERIVATIVE; BREFELDIN A; CARBOXY ADAMANTYL GLOBOTRIAOSYLCERAMIDE; CERAMIDE DERIVATIVE; CHOLERA TOXIN; CHOLERA TOXIN GM1; CHOLESTEROL; HYDROXYETHYL ADAMANTYL GLOBOTRIAOSYLCERAMIDE; LIPOSOME; UNCLASSIFIED DRUG; UREA ADAMANTYL GLOBOTRIAOSYLCERAMIDE; VEROTOXIN 1; VEROTOXIN 2;

ANIMAL CELL; ARTICLE; CELL PROTECTION; CELL VACUOLE; CHO CELL; COMPETITIVE INHIBITION; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOPATHOGENIC EFFECT; CYTOTOXICITY; ENDOPLASMIC RETICULUM; ENDOSOME; GOLGI COMPLEX; INCUBATION TIME; INTERNALIZATION; INTRACELLULAR TRANSPORT; LEUKEMIA CELL LINE; NONHUMAN; PRIORITY JOURNAL; PROTEIN LIPID INTERACTION; RECEPTOR BINDING; STRUCTURE ACTIVITY RELATION; TOXICOKINETICS; VERO CELL;

ADAMANTANE; ANIMALS; BIOLOGICAL TRANSPORT, ACTIVE; CELL MEMBRANE; CERCOPITHECUS AETHIOPS; CHO CELLS; CHOLESTEROL; CRICETINAE; CRICETULUS; ENDOPLASMIC RETICULUM; ENDOSOMES; HEK293 CELLS; HUMANS; SHIGA TOXIN 1; SHIGA TOXIN 2; STRUCTURE-ACTIVITY RELATIONSHIP; TRIHEXOSYLCERAMIDES; VERO CELLS;

EID: 84860871097     PISSN: 00219258     EISSN: 1083351X     Source Type: Journal    
DOI: 10.1074/jbc.M111.318196     Document Type: Article

References (89)

1. Spitalnik, P. F., and Spitalnik, S. L. (1995) The P blood group system. Biochemical, serological, and clinical aspects. Transfus. Med. Rev. 9, 110-122
2. Mangeney, M., Richard, Y., Coulaud, D., Tursz, T., and Wiels, J. (1991) CD77. An antigen of germinal center B cells entering apoptosis. Eur. J. Immunol. 21, 1131-1140
3. O'Brien, A. D., Tesh, V. L., Donohue-Rolfe, A., Jackson, M. P., Olsnes, S., Sandvig, K., Lindberg, A. A., and Keusch, G. T. (1992) Shiga toxin. Biochemistry, genetics, mode of action, and role in pathogenesis. Curr. Top. Microbiol. Immunol. 180, 65-94
4. Karmali, M. A., Gannon, V., and Sargeant, J. M. (2010) Verocytotoxin-producing Escherichia coli (VTEC). Vet. Microbiol. 140, 360-370
5. Richardson, S. E., Karmali, M. A., Becker, L. E., and Smith, C. R. (1988) The histopathology of the hemolytic uremic syndrome associated with vero-cytotoxin-producing Escherichia coli infections. Hum. Pathol. 19, 1102-1108
6. Müthing, J., Schweppe, C. H., Karch, H., and Friedrich, A. W. (2009) Shiga toxins, glycosphingolipid diversity, and endothelial cell injury. Thromb. Haemost. 101, 252-264
7. Goldwater, P. N. (2007) Treatment and prevention of enterohemorrhagic Escherichia coli infection and hemolytic uremic syndrome. Expert Rev. Anti Infect. Ther. 5, 653-663
8. Bielaszewska, M., Mellmann, A., Zhang, W., Köck, R., Fruth, A., Bauwens, A., Peters, G., and Karch, H. (2011) Characterization of the Escherichia coli strain associated with an outbreak of haemolytic uraemic syndrome in Germany, 2011. A microbiological study. Lancet Infect. Dis. 11, 671-676
9. Frank, C., Werber, D., Cramer, J. P., Askar, M., Faber, M., an der Heiden, M., Bernard, H., Fruth, A., Prager, R., Spode, A., Wadl, M., Zoufaly, A., Jordan, S., Kemper, M. J., Follin, P., Müller, L., King, L. A., Rosner, B., Buchholz, U., Stark, K., Krause, G., and HUS Investigation Team (2011) Epidemic profile of Shiga toxin-producing Escherichia coli O104:H4 outbreak in Germany. N. Engl. J. Med. 365, 1771-1780
10. Karch, H., Friedrich, A. W., Gerber, A., Zimmerhackl, L. B., Schmidt, M. A., and Bielaszewska, M. (2006) New aspects in the pathogenesis of enteropathic hemolytic uremic syndrome. Semin. Thromb. Hemost. 32, 105-112
11. Kawano, K., Okada, M., Haga, T., Maeda, K., and Goto, Y. (2008) Relationship between pathogenicity for humans and stx genotype in Shiga toxin-producing Escherichia coli serotype O157. Eur. J. Clin. Microbiol. Infect. Dis. 27, 227-232
12. Tam, P., Mahfoud, R., Nutikka, A., Khine, A. A., Binnington, B., Paroutis, P., and Lingwood, C. (2008) Differential intracellular transport and binding of verotoxin 1 and verotoxin 2 to globotriaosylceramide-containing lipid assemblies. J. Cell. Physiol. 216, 750-763
13. Okuda, T., Tokuda, N., Numata, S., Ito, M., Ohta, M., Kawamura, K., Wiels, J., Urano, T., Tajima, O., and Furukawa, K. (2006) Targeted disruption of Gb3/CD77 synthase gene resulted in the complete deletion of globo-series glycosphingolipids and loss of sensitivity to verotoxins. J. Biol. Chem. 281, 10230-10235 (Pubitemid 43864560)
14. Nyholm, P. G., Magnusson, G., Zheng, Z., Norel, R., Binnington-Boyd, B., and Lingwood, C. A. (1996) Two distinct binding sites for globotriaosyl ceramide on verotoxins. Identification by molecular modeling and confirmation using deoxy analogues and a new glycolipid receptor for all verotoxins. Chem. Biol. 3, 263-275 (Pubitemid 126663325)
15. Chark, D., Nutikka, A., Trusevych, N., Kuzmina, J., and Lingwood, C. (2004) Differential carbohydrate epitope recognition of globotriaosyl ceramide by verotoxins and monoclonal antibody: Role in human renal glomerular binding. Eur. J. Biochem. 271, 405-417 (Pubitemid 38130468)
16. Mahfoud, R., Manis, A., and Lingwood, C. (2009) Fatty acid-dependent globotriaosyl ceramide receptor function in detergent-resistant model membranes. J. Lipid Res. 50, 1744-1755
17. Khan, F., Proulx, F., and Lingwood, C. A. (2009) Detergent-resistant globotriaosyl ceramide may define verotoxin/glomeruli-restricted hemolytic uremic syndrome pathology. Kidney Int. 75, 1209-1216
18. Yahi, N., Aulas, A., and Fantini, J. (2010) How cholesterol constrains glycolipid conformation for optimal recognition of Alzheimer's β amyloid peptide (Aβ1-40). PLoS One 5, e9079
19. Kaiser, H. J., Lingwood, D., Levental, I., Sampaio, J. L., Kalvodova, L., Rajendran, L., and Simons, K. (2009) Order of lipid phases in model and plasma membranes. Proc. Natl. Acad. Sci. U.S.A. 106, 16645-16650
20. Lingwood, D., Binnington, B., Róg, T., Vattulainen, I., Grzybek, M., Coskun, U., Lingwood, C. A., and Simons, K. (2011) Cholesterol modulates glycolipid conformation and receptor activity. Nat. Chem. Biol. 7, 260-262
21. Mahfoud, R., Manis, A., Binnington, B., Ackerley, C., and Lingwood, C. A. (2010) A major fraction of glycosphingolipids in model and cellular cholesterol- containing membranes is undetectable by their binding proteins. J. Biol. Chem. 285, 36049-36059
22. Falguières, T., Mallard, F., Baron, C., Hanau, D., Lingwood, C., Goud, B., Salamero, J., and Johannes, L. (2001) Targeting of Shiga toxin B-subunit to retrograde transport route in association with detergent-resistant membranes. Mol. Biol. Cell 12, 2453-2468 (Pubitemid 33051968)
23. Smith, D. C., Sillence, D. J., Falguières, T., Jarvis, R. M., Johannes, L., Lord, J. M., Platt, F. M., and Roberts, L. M. (2006) The association of Shiga-like toxin with detergent-resistant membranes is modulated by glucosylceramide and is an essential requirement in the endoplasmic reticulum for a cytotoxic effect. Mol. Biol. Cell 17, 1375-1387 (Pubitemid 43376557)
24. Hooper, N. (1999) Detergent-insoluble glycosphingolipid/cholesterol-rich membrane domains, lipid rafts and caveolae (review). Mol. Membr. Biol. 16, 145-156
25. 3interaction. J. Lipid Res. 43, 1670-1679
26. Sandvig, K., Olsnes, S., Brown, J. E., Petersen, O. W., and van Deurs, B. (1989) Endocytosis from coated pits of Shiga toxin. A glycolipid-binding protein from Shigella dysenteriae 1. J. Cell Biol. 108, 1331-1343 (Pubitemid 19097041)
27. Nichols, B. J., Kenworthy, A. K., Polishchuk, R. S., Lodge, R., Roberts, T. H., Hirschberg, K., Phair, R. D., and Lippincott-Schwartz, J. (2001) Rapid cycling of lipid raft markers between the cell surface and Golgi complex. J. Cell Biol. 153, 529-541 (Pubitemid 34280140)
28. Sandvig, K., Garred, O., Prydz, K., Kozlov, J. V., Hansen, S. H., and van Deurs, B. (1992) Retrograde transport of endocytosed Shiga toxin to the endoplasmic reticulum. Nature 358, 510-512
29. Tam, P. J., and Lingwood, C. A. (2007) Membrane cytosolic translocation of verotoxin A1 subunit in target cells. Microbiology 153, 2700-2710 (Pubitemid 47262059)
30. Hoey, D. E., Sharp, L., Currie, C., Lingwood, C. A., Gally, D. L., and Smith, D. G. (2003) Verotoxin 1 binding to intestinal crypt epithelial cells results in localization to lysosomes and abrogation of toxicity. Cell. Microbiol. 5, 85-97 (Pubitemid 36395123)
31. Pagano, R. E., Puri, V., Dominguez, M., and Marks, D. L. (2000) Membrane traffic in sphingolipid storage diseases. Traffic 1, 807-815
32. Johannes, L., Pezo, V., Mallard, F., Tenza, D., Wiltz, A., Saint-Pol, A., Helft, J., Antony, C., and Benaroch, P. (2003) Effects of HIV-1 Nef on retrograde transport from the plasma membrane to the endoplasmic reticulum. Traffic 4, 323-332 (Pubitemid 36582634)
33. Kiarash, A., Boyd, B., and Lingwood, C. A. (1994) Glycosphingolipid receptor function is modified by fatty acid content. Verotoxin 1 and verotoxin 2c preferentially recognize different globotriaosyl ceramide fatty acid homologues. J. Biol. Chem. 269, 11138-11146
34. Boyd, B., Magnusson, G., Zhiuyan, Z., and Lingwood, C. A. (1994) Lipid modulation of glycolipid receptor function. Availability of Gal(α1-4)Gal disaccharide for verotoxin binding in natural and synthetic glycolipids. Eur. J. Biochem. 223, 873-878 (Pubitemid 24263171)
35. Arab, S., and Lingwood, C. A. (1996) Influence of phospholipid chain length on verotoxin/globotriaosyl ceramide binding in model membranes. Comparison of a supported bilayer film and liposomes. Glycoconj. J. 13, 159-166 (Pubitemid 26132723)
36. Lingwood, C. A. (1996) Aglycone modulation of glycolipid receptor function. Glycoconj. J. 13, 495-503
37. Sandvig, K., and van Deurs, B. (2002) Transport of protein toxins into cells. Pathways used by ricin, cholera toxin, and Shiga toxin. FEBS Lett. 529, 49-53 (Pubitemid 35283911)
38. Lencer, W. I., and Tsai, B. (2003) The intracellular voyage of cholera toxin. Going retro. Trends Biochem. Sci. 28, 639-645 (Pubitemid 37500898)
39. Pagano, R. E., Watanabe, R., Wheatley, C., and Dominguez, M. (2000) Applications of BODIPY-sphingolipid analogs to study lipid traffic and metabolism in cells. Methods Enzymol. 312, 523-534
40. Kitov, P. I., Sadowska, J. M., Mulvey, G., Armstrong, G. D., Ling, H., Pannu, N. S., Read, R. J., and Bundle, D. R. (2000) Shiga-like toxins are neutralized by tailored multivalent carbohydrate ligands. Nature 403, 669-672 (Pubitemid 30104009)
41. Nishikawa, K., Matsuoka, K., Watanabe, M., Igai, K., Hino, K., Hatano, K., Yamada, A., Abe, N., Terunuma, D., Kuzuhara, H., and Natori, Y. (2005) Identification of the optimal structure required for a Shiga toxin neutralizer with oriented carbohydrates to function in the circulation. J. Infect. Dis. 191, 2097-2105 (Pubitemid 40800581)
42. Kitov, P. I., Mulvey, G. L., Griener, T. P., Lipinski, T., Solomon, D., Paszkiewicz, E., Jacobson, J. M., Sadowska, J. M., Suzuki, M., Yamamura, K., Armstrong, G. D., and Bundle, D. R. (2008) In vivo supramolecular templating enhances the activity of multivalent ligands. A potential therapeutic against the Escherichia coli O157 AB5 toxins. Proc. Natl. Acad. Sci. U.S.A. 105, 16837-16842
43. St Hilaire, P. M., Boyd, M. K., and Toone, E. J. (1994) Interaction of the Shiga-like toxin type 1 B-subunit with its carbohydrate receptor. Biochemistry 33, 14452-14463
44. Mylvaganam, M., and Lingwood, C. (1999) Adamantyl globotriaosyl ceramide. A monovalent soluble mimic which inhibits verotoxin binding to its glycolipid receptor. Biochem. Biophys. Res. Commun. 257, 391-394 (Pubitemid 29301455)
45. Mylvaganam, M., and Lingwood, C. A. (2003) A preamble to aglycone reconstruction for membrane-presented glycolipids. in Carbohydrate-based Drug Discovery (Wong, C.-H., ed) pp. 761-780, Wiley-VCH Press, Weinheim, Germany
46. Rutjes, N. W., Binnington, B. A., Smith, C. R., Maloney, M. D., and Lingwood, C. A. (2002) Differential tissue targeting and pathogenesis of verotoxins 1 and 2 in the mouse animal model. Kidney Int. 62, 832-845 (Pubitemid 35316712)
47. Petric, M., Karmali, M. A., Richardson, S., and Cheung, R. (1987) Purification and biological properties of Escherichia coli verocytotoxin FEMS Microbiol. Lett. 41, 63-68 (Pubitemid 17030524)
48. Niu, S. L., and Litman, B. J. (2002) Determination of membrane cholesterol partition coefficient using a lipid vesicle-cyclodextrin binary system. Effect of phospholipid acyl chain unsaturation and headgroup composition. Biophys. J. 83, 3408-3415
49. Halling, K. K., Ramstedt, B., Nyström, J. H., Slotte, J. P., and Nyholm, T. K. (2008) Cholesterol interactions with fluid-phase phospholipids. Effect on the lateral organization of the bilayer. Biophys. J. 95, 3861-3871
50. Wolf, A. A., Jobling, M. G., Saslowsky, D. E., Kern, E., Drake, K. R., Kenworthy, A. K., Holmes, R. K., and Lencer, W. I. (2008) Attenuated endocytosis and toxicity of a mutant cholera toxin with decreased ability to cluster ganglioside GM1 molecules. Infect. Immun. 76, 1476-1484 (Pubitemid 351561991)
51. Khine, A. A., Tam, P., Nutikka, A., and Lingwood, C. A. (2004) Brefeldin A and filipin distinguish two globotriaosyl ceramide/verotoxin-1 intracellular trafficking pathways involved in Vero cell cytotoxicity. Glycobiology 14, 701-712 (Pubitemid 39161977)
52. Sandvig, K., and van Deurs, B. (1994) Endocytosis and intracellular sorting of ricin and Shiga toxin. FEBS Lett. 346, 99-102 (Pubitemid 24183836)
53. Veiga, M. P., Arrondo, J. L., Goñi, F. M., Alonso, A., and Marsh, D. (2001) Interaction of cholesterol with sphingomyelin in mixed membranes containing phosphatidylcholine, studied by spin-label ESR and IR spectroscopies. A possible stabilization of gel-phase sphingolipid domains by cholesterol. Biochemistry 40, 2614-2622 (Pubitemid 32171737)
54. Majoul, I., Schmidt, T., Pomasanova, M., Boutkevich, E., Kozlov, Y., and Söling, H. D. (2002) Differential expression of receptors for Shiga and cholera toxin is regulated by the cell cycle. J. Cell Sci. 115, 817-826 (Pubitemid 34196341)
55. Rosales Fritz, V. M., Daniotti, J. L., and Maccioni, H. J. (1997) Chinese hamster ovary cells lacking GM1 and GD1a synthesize gangliosides upon transfection with human GM2 synthase. Biochim. Biophys. Acta 1354, 153-158 (Pubitemid 27513075)
56. Lingwood, C. A., Binnington, B., Manis, A., and Branch, D. R. (2010) Globotriaosyl ceramide receptor function. Where membrane structure and pathology intersect. FEBS Lett. 584, 1879-1886
57. Lingwood, C. A., Manis, A., Mahfoud, R., Khan, F., Binnington, B., and Mylvaganam, M. (2010) New aspects of the regulation of glycosphingolipid receptor function. Chem. Phys. Lipids 163, 27-35
58. Sandvig, K., Bergan, J., Dyve, A. B., Skotland, T., and Torgersen, M. L. (2009) Endocytosis and retrograde transport of Shiga toxin. Toxicon 56, 1181-1185
59. Arab, S., Rutka, J., and Lingwood, C. (1999) Verotoxin induces apoptosis and the complete, rapid, long-term elimination of human astrocytoma xenografts in nude mice. Oncol. Res. 11, 33-39
60. Salhia, B., Rutka, J. T., Lingwood, C., Nutikka, A., and Van Furth, W. R. (2002) The treatment of malignant meningioma with verotoxin. Neoplasia 4, 304-311 (Pubitemid 34755840)
61. + hematopoietic stem cells: Implications for ex vivo tumor purging and autologous stem cell transplantation. Blood 94, 2901-2910
62. Falguières, T., Maak, M., von Weyhern, C., Sarr, M., Sastre, X., Poupon, M. F., Robine, S., Johannes, L., and Janssen, K. P. (2008) Human colorectal tumors and metastases express Gb3 and can be targeted by an intestinal pathogen-based delivery tool. Mol. Cancer Ther. 7, 2498-2508
63. Amessou, M., Carrez, D., Patin, D., Sarr, M., Grierson, D. S., Croisy, A., Tedesco, A. C., Maillard, P., and Johannes, L. (2008) Retrograde delivery of photosensitizer (TPPp-O-β-GluOH)3 selectively potentiates its photodynamic activity. Bioconjug. Chem. 19, 532-538 (Pubitemid 351294926)
64. Devenica, D., Čikeš Čulić, V., Vuica, A., and Markotić, A. (2011) Biochemical, pathological and oncological relevance of Gb3Cer receptor. Med. Oncol. 28, S675-S684
65. Heath-Engel, H. M., and Lingwood, C. A. (2003) Verotoxin sensitivity of ECV304 cells in vitro and in vivo in a xenograft tumor model. VT1 as a tumor neovascular marker. Angiogenesis 6, 129-141 (Pubitemid 38173864)
66. Johansson, D., Kosovac, E., Moharer, J., Ljuslinder, I., Brännström, T., Johansson, A., and Behnam-Motlagh, P. (2009) Expression of verotoxin-1 receptor Gb3 in breast cancer tissue and verotoxin-1 signal transduction to apoptosis. BMC Cancer 9, 67
67. Lund, N., Olsson, M. L., Ramkumar, S., Sakac, D., Yahalom, V., Levene, C., Hellberg, A., Ma, X. Z., Binnington, B., Jung, D., Lingwood, C. A., and Branch, D. R. (2009) The human pk histo-blood group antigen provides protection against HIV-1 infection. Blood 113, 4980-4991
68. Sillence, D. J., Puri, V., Marks, D. L., Butters, T. D., Dwek, R. A., Pagano, R. E., and Platt, F. M. (2002) Glucosylceramide modulates membrane traffic along the endocytic pathway. J. Lipid Res. 43, 1837-1845 (Pubitemid 35315801)
69. Patterson, G. H., Hirschberg, K., Polishchuk, R. S., Gerlich, D., Phair, R. D., and Lippincott-Schwartz, J. (2008) Transport through the Golgi apparatus by rapid partitioning within a two-phase membrane system. Cell 133, 1055-1067 (Pubitemid 351795609)
70. Zhang, H., Abraham, N., Khan, L. A., Hall, D. H., Fleming, J. T., and Göbel, V. (2011) Apicobasal domain identities of expanding tubular membranes depend on glycosphingolipid biosynthesis. Nat. Cell Biol. 13, 1189-1201
71. Lingwood, C. A., Sadacharan, S., Abul-Milh, A., Mylvaganam, M., and Peter, M. (2006) Soluble adamantyl glycosphingolipid analogs as probes of glycosphingolipid function. in Glycobiology Protocols (Braukhausen, I., ed) pp. 305-320, Humana Press, Totowa, NJ
72. Kamani, M., Mylvaganam, M., Tian, R., Rigat, B., Binnington, B., and Lingwood, C. (2011) Adamantyl glycosphingolipids provide a new approach to the selective regulation of cellular glycosphingolipid metabolism. J. Biol. Chem. 286, 21413-21426
73. McKenzie, J., Johannes, L., Taguchi, T., and Sheff, D. (2009) Passage through the Golgi is necessary for Shiga toxin B subunit to reach the endoplasmic reticulum. FEBS J. 276, 1581-1595
74. Lingwood, D., Ries, J., Schwille, P., and Simons, K. (2008) Plasma membranes are poised for activation of raft phase coalescence at physiological temperature. Proc. Natl. Acad. Sci. U.S.A. 105, 10005-10010
75. Schwarzmann, G. (2001) Uptake and metabolism of exogenous glycosphingolipids by cultured cells. Semin. Cell Dev. Biol. 12, 163-171
76. Soltyk, A. M., MacKenzie, C. R., Wolski, V. M., Hirama, T., Kitov, P. I., Bundle, D. R., and Brunton, J. L. (2002) A mutational analysis of the globotriaosylceramide- binding sites of verotoxin VT1. J. Biol. Chem. 277, 5351-5359 (Pubitemid 34968581)
77. Windschiegl, B., Orth, A., Römer, W., Berland, L., Stechmann, B., Bassereau, P., Johannes, L., and Steinem, C. (2009) Lipid reorganization induced by Shiga toxin clustering on planar membranes. PLoS One 4, e6238
78. Schapiro, F. B., Lingwood, C., Furuya, W., and Grinstein, S. (1998) pH-independent retrograde targeting of glycolipids to the Golgi complex. Am. J. Physiol. 274, C319-C332
79. Lauvrak, S. U., Torgersen, M. L., and Sandvig, K. (2004) Efficient endosome- to-Golgi transport of Shiga toxin is dependent on dynamin and clathrin. J. Cell Sci. 117, 2321-2331 (Pubitemid 38807499)
80. Saint-Pol, A., Yélamos, B., Amessou, M., Mills, I. G., Dugast, M., Tenza, D., Schu, P., Antony, C., McMahon, H. T., Lamaze, C., and Johannes, L. (2004) Clathrin adaptor epsinR is required for retrograde sorting on early endosomal membranes. Dev. Cell 6, 525-538 (Pubitemid 38456181)
81. Rodal, S. K., Skretting, G., Garred, O., van Deurs, B., and Sandvig, K. (1999) Extraction of cholesterol with methyl-β-cyclodextrin perturbs formation of clathrin-coated endocytic vesicles. Mol. Biol. Cell 10, 961-974 (Pubitemid 29193724)
82. Le, P. U., and Nabi, I. R. (2003) Distinct caveolae-mediated endocytic pathways target the Golgi apparatus and the endoplasmic reticulum. J. Cell Sci. 116, 1059-1071 (Pubitemid 36395616)
83. Badizadegan, K., Wheeler, H. E., Fujinaga, Y., and Lencer, W. I. (2004) Trafficking of cholera toxin-ganglioside GM1 complex into Golgi and induction of toxicity depend on actin cytoskeleton. Am. J. Physiol. Cell Physiol. 287, C1453-C1462 (Pubitemid 39382907)
84. Spilsberg, B., Van Meer, G., and Sandvig, K. (2003) Role of lipids in the retrograde pathway of ricin intoxication. Traffic 4, 544-552 (Pubitemid 36896546)
85. Bacia, K., Schwille, P., and Kurzchalia, T. (2005) Sterol structure determines the separation of phases and the curvature of the liquid-ordered phase in model membranes. Proc. Natl. Acad. Sci. U.S.A. 102, 3272-3277 (Pubitemid 40328035)
86. Puri, V., Watanabe, R., Dominguez, M., Sun, X., Wheatley, C. L., Marks, D. L., and Pagano, R. E. (1999) Cholesterol modulates membrane traffic along the endocytic pathway in sphingolipid-storage diseases. Nat. Cell Biol. 1, 386-388 (Pubitemid 129493583)
87. Hall, A., Róg, T., Karttunen, M., and Vattulainen, I. (2010) Role of glycolipids in lipid rafts. A view through atomistic molecular dynamics simulations with galactosylceramide. J. Phys. Chem. B 114, 7797-7807
88. Nyholm, P. G., and Pascher, I. (1993) Orientation of the saccharide chains of glycolipids at the membrane surface. Conformational analysis of the glucose-ceramide and the glucose-glyceride linkages using molecular mechanics (MM3). Biochemistry 32, 1225-1234
89. Calander, N., Karlsson, K. A., Nyholm, P. G., and Pascher, I. (1988) On the dissection of binding epitopes on carbohydrate receptors for microbes using molecular modeling. Biochimie 70, 1673-1682